Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Vitamin Well Danmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1%   Bankruptcy risk   3.5% 3.2% 3.1% 3.3% 1.5% 1.4% 6.5% 6.5%   Credit score (0-100)   55 56 55 55 76 79 37 37   Credit rating   BBB BBB BBB BBB A A BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 244.8 530.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 0.0 0.0 21,643 30,996 0.0 0.0   EBITDA   2,630 2,267 2,915 4,065 6,020 7,297 0.0 0.0   EBIT   2,630 2,267 2,915 4,065 4,297 4,988 0.0 0.0   Pre-tax profit (PTP)   1,354.0 1,804.0 2,296.0 2,831.0 3,061.0 4,052.0 0.0 0.0   Net earnings   1,354.0 1,804.0 2,296.0 2,831.0 2,320.0 3,128.0 0.0 0.0   Pre-tax profit without non-rec. items   2,630 2,267 2,915 4,065 3,061 4,052 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 1,873 6,695 0.0 0.0   Shareholders equity total   14,688 16,492 18,788 21,619 38,940 42,068 42,005 42,005   Interest-bearing liabilities   0.0 0.0 0.0 0.0 20,621 44,372 0.0 0.0   Balance sheet total (assets)   59,423 43,460 50,358 92,681 87,030 120,836 42,005 42,005   Net Debt   0.0 0.0 0.0 0.0 15,514 36,759 -42,005 -42,005     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 0.0 0.0 21,643 30,996 0.0 0.0   Gross profit growth   -100.0% 0.0% 0.0% 0.0% 0.0% 43.2% -100.0% 0.0%   Employees   36 30 26 30 31 38 0 0   Employee growth %   50.0% -16.7% -13.3% 15.4% 3.3% 22.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   59,423 43,460 50,358 92,681 87,030 120,836 42,005 42,005   Balance sheet change%   23.5% -26.9% 15.9% 84.0% -6.1% 38.8% -65.2% 0.0%   Added value   2,630.0 2,267.0 2,915.0 4,065.0 4,297.0 7,297.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,948 0 0 0 150 2,513 -6,695 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 0.0% 0.0% 19.9% 16.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.9% 4.4% 6.2% 5.7% 5.0% 5.0% 0.0% 0.0%   ROI %   5.5% 4.4% 6.2% 5.7% 5.9% 7.0% 0.0% 0.0%   ROE %   16.3% 11.6% 13.0% 14.0% 7.7% 7.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   100.0% 100.0% 100.0% 100.0% 44.7% 34.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% 257.7% 503.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 53.0% 105.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 13.9% 3.5% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 5,107.0 7,613.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 0.0 0.0 36,657.0 35,974.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   73 76 112 136 139 192 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   73 76 112 136 194 192 0 0   EBIT / employee   73 76 112 136 139 131 0 0   Net earnings / employee   38 60 88 94 75 82 0 0